Literature DB >> 23958507

Is percutaneous nephrolithotomy in solitary kidneys safe?

Kathie Alexina Wong1, Arun Sahai, Amit Patel, Kay Thomas, Matthew Bultitude, Jonathan Glass.   

Abstract

OBJECTIVE: To review our experience from a high volume stone center with a focus on efficacy, safety, and renal function.
METHODS: Stones requiring percutaneous nephrolithotomy (PCNL) in patients with solitary kidneys can pose significant anxiety to the urologist. Limited data are available in published reports in this setting. A comprehensive retrospective review of medical records was performed on patients who underwent PCNL and had a solitary kidney or a single functioning renal unit. Data were collected on patient demographics, stone burden, outcomes, complications, and renal function.
RESULTS: Of 378 PCNLs performed between January 2003 and September 2011, 22 were performed in 17 patients with a single functioning kidney. Three procedures were performed in a transplanted kidney. In those with solitary calculus, the longest mean length and stone surface area were 37 mm and 825 mm(2), respectively. Stone-free rate was 59%. Auxiliary procedures were required in 6 cases, resulting in a stone-free rate of 77%. Median inpatient stay was 4 days. Serum creatinine values improved from 144 to 126 umol/L before and after the procedure and mean estimated glomerular filtration rate improved similarly from 51 to 59 mls/minute, respectively. Blood transfusion was required in 1 patient, sepsis developed in 3, and 2 patients required a stent for obstruction.
CONCLUSION: PCNL in solitary kidneys is safe with an acceptable complication rate if performed in a high volume center. Outcomes are good, although auxiliary procedures may be necessary. Renal function remains stable or improves after procedure.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23958507     DOI: 10.1016/j.urology.2013.06.034

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  Minimally invasive treatment of renal transplant nephrolithiasis.

Authors:  He-jia Yuan; Dian-dong Yang; Yuan-shan Cui; Chang-ping Men; Zhen-li Gao; L Shi; Ji-tao Wu
Journal:  World J Urol       Date:  2015-04-02       Impact factor: 4.226

2.  Recurrent waist tumor subsequent to percutaneous nephrolithotomy: A case report.

Authors:  Shusuan Jiang; Sulai Liu; Pingping Tan; Tieyong Song; Y U Xie; Fuhua Zeng; Zhizhong Liu; Weiqing Han; Zengnan Mo; Lin Qi
Journal:  Oncol Lett       Date:  2015-05-04       Impact factor: 2.967

3.  Is retrograde intrarenal surgery a viable treatment option for renal stones in patients with solitary kidney?

Authors:  G Giusti; S Proietti; L Cindolo; R Peschechera; G Sortino; F Berardinelli; G Taverna
Journal:  World J Urol       Date:  2014-04-23       Impact factor: 4.226

4.  Intrarenal pseudoaneurysm after percutaneous nephrolithotomy at solitary kidney.

Authors:  Hakan Ozturk
Journal:  Nephrourol Mon       Date:  2014-09-05

Review 5.  Cystinuria-a urologist's perspective.

Authors:  Kay Thomas; Kathie Wong; John Withington; Matthew Bultitude; Angela Doherty
Journal:  Nat Rev Urol       Date:  2014-03-25       Impact factor: 14.432

6.  Percutaneous nephrolithotomy in patients with solitary kidney: a critical outcome analysis.

Authors:  Fabio C M Torricelli; Guilherme P Padovani; Giovanni S Marchini; Fabio C Vicentini; Alexandre Danilovic; Sabrina T Reis; Miguel Srougi; Eduardo Mazzucchi
Journal:  Int Braz J Urol       Date:  2015 May-Jun       Impact factor: 1.541

7.  Safety and outcome of percutaneous nephrolithotomy in patients with solitary kidney: A tertiary care center experience.

Authors:  Uday Pratap Singh; Sanjoy Kumar Sureka; Kumar Madhavan; Anubhav Raj; M S Ansari; Rakesh Kapoor; Aneesh Srivastava
Journal:  Indian J Urol       Date:  2019 Oct-Dec

Review 8.  Outcomes of ureteroscopy for patients with stones in a solitary kidney: evidence from a systematic review.

Authors:  Patrick Jones; Bhavan Prasad Rai; Bhaskar K Somani
Journal:  Cent European J Urol       Date:  2016-01-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.